Ardelyx Management
Management criteria checks 4/4
Ardelyx's CEO is Mike Raab, appointed in Mar 2009, has a tenure of 15.17 years. total yearly compensation is $1.95M, comprised of 33.4% salary and 66.6% bonuses, including company stock and options. directly owns 0.57% of the company’s shares, worth $8.60M. The average tenure of the management team and the board of directors is 3.9 years and 8.3 years respectively.
Key information
Mike Raab
Chief executive officer
US$1.9m
Total compensation
| CEO salary percentage | 33.4% |
| CEO tenure | 15.2yrs |
| CEO ownership | 0.6% |
| Management average tenure | 3.9yrs |
| Board average tenure | 8.3yrs |
Recent management updates
Recent updates
Ardelyx, Inc.'s (NASDAQ:ARDX) Popularity With Investors Is Under Threat From Overpricing
Apr 17
Ardelyx Shrugs Off 'Mixed' Q4 Earnings
Mar 13Earnings Update: Ardelyx, Inc. (NASDAQ:ARDX) Just Reported Its Yearly Results And Analysts Are Updating Their Forecasts
Feb 24Ardelyx Q4 Preview: Recent Bull Run May Pause While Market Digests 2024 Guidance
Feb 20Ardelyx's XPHOZAH Still An Afterthought To The Pros
Jan 31Ardelyx: FDA Approval For Xphozah Grants Further Sales Enhancement
Jan 10Ardelyx, Inc.'s (NASDAQ:ARDX) Business Is Yet to Catch Up With Its Share Price
Jan 04Despite Lacking Profits Ardelyx (NASDAQ:ARDX) Seems To Be On Top Of Its Debt
Dec 14Party Time: Brokers Just Made Major Increases To Their Ardelyx, Inc. (NASDAQ:ARDX) Earnings Forecasts
Aug 03Rock star Growth Puts Ardelyx (NASDAQ:ARDX) In A Position To Use Debt
Jul 31Pinning Down Ardelyx, Inc.'s (NASDAQ:ARDX) P/S Is Difficult Right Now
Apr 17Is Ardelyx (NASDAQ:ARDX) Using Debt Sensibly?
Mar 30Is Ardelyx (NASDAQ:ARDX) Using Debt Sensibly?
Dec 14What To Expect For Ardelyx In The Coming Month
Oct 18Ardelyx: Potential For Growth, But Must Strengthen Its Financial Position
Oct 04Ardelyx secures $20M financial deal with HealthCare Royalty on tenapanor potential sale
Jun 30Ardelyx Is Down, Long Live Ardelyx
Jan 28Analysts' Revenue Estimates For Ardelyx, Inc. (NASDAQ:ARDX) Are Surging Higher
Dec 02Ardelyx: Indecisive Regulators, Frustrated Company, Gruelling Wait For Investors
Oct 25CEO Compensation Analysis
| Date | Total Compensation | Salary | Company Earnings |
|---|---|---|---|
| Dec 31 2023 | n/a | n/a | -US$66m |
| Sep 30 2023 | n/a | n/a | -US$27m |
| Jun 30 2023 | n/a | n/a | -US$56m |
| Mar 31 2023 | n/a | n/a | -US$66m |
| Dec 31 2022 | US$2m | US$650k | -US$67m |
| Sep 30 2022 | n/a | n/a | -US$114m |
| Jun 30 2022 | n/a | n/a | -US$135m |
| Mar 31 2022 | n/a | n/a | -US$153m |
| Dec 31 2021 | US$4m | US$650k | -US$158m |
| Sep 30 2021 | n/a | n/a | -US$151m |
| Jun 30 2021 | n/a | n/a | -US$125m |
| Mar 31 2021 | n/a | n/a | -US$105m |
| Dec 31 2020 | US$4m | US$633k | -US$94m |
| Sep 30 2020 | n/a | n/a | -US$85m |
| Jun 30 2020 | n/a | n/a | -US$91m |
| Mar 31 2020 | n/a | n/a | -US$91m |
| Dec 31 2019 | US$2m | US$595k | -US$95m |
| Sep 30 2019 | n/a | n/a | -US$103m |
| Jun 30 2019 | n/a | n/a | -US$104m |
| Mar 31 2019 | n/a | n/a | -US$100m |
| Dec 31 2018 | US$4m | US$575k | -US$91m |
| Sep 30 2018 | n/a | n/a | -US$53m |
| Jun 30 2018 | n/a | n/a | -US$50m |
| Mar 31 2018 | n/a | n/a | -US$53m |
| Dec 31 2017 | US$5m | US$555k | -US$64m |
Compensation vs Market: Mike's total compensation ($USD1.95M) is below average for companies of similar size in the US market ($USD5.72M).
Compensation vs Earnings: Mike's compensation has been consistent with company performance over the past year.
CEO
Mike Raab (58 yo)
15.2yrs
Tenure
US$1,947,020
Compensation
Mr. Michael G. Raab, also known as Mike, has been the Chief Executive Officer and President of Ardelyx, Inc. since March 2009. He is a Director of Tempest Therapeutics Inc. since May 2019 and its Chairman...
Leadership Team
| Name | Position | Tenure | Compensation | Ownership |
|---|---|---|---|---|
| President | 15.2yrs | US$1.95m | 0.57% $ 8.6m | |
| Chief Commercial Officer | 4yrs | US$1.04m | 0.19% $ 2.9m | |
| Chief Medical Officer | 3.5yrs | US$1.06m | 0.16% $ 2.4m | |
| Chief Financial & Operations Officer and Treasurer | 3.9yrs | US$1.73m | 0.13% $ 2.0m | |
| Senior VP of Finance & Chief Accounting Officer | 2.2yrs | no data | 0.079% $ 1.2m | |
| Chief Legal & Administrative Officer and Secretary | 10yrs | US$1.73m | 0.13% $ 2.0m | |
| Vice President of Corporate Communications & Investor Relations | no data | no data | no data | |
| Executive Vice President of Corporate Development & Strategy | less than a year | no data | no data | |
| Chief Human Resources Officer | 1.3yrs | no data | no data | |
| Chief Development Officer | 9.3yrs | US$1.63m | 0.27% $ 4.1m | |
| Chief Regulatory Affairs & Quality Assurance Officer | no data | US$1.70m | 0.16% $ 2.4m | |
| Senior Director of Market Development | no data | no data | no data |
3.9yrs
Average Tenure
59yo
Average Age
Experienced Management: ARDX's management team is considered experienced (3.9 years average tenure).
Board Members
| Name | Position | Tenure | Compensation | Ownership |
|---|---|---|---|---|
| President | 15.2yrs | US$1.95m | 0.57% $ 8.6m | |
| Independent Chairman of the Board | 15.2yrs | US$141.65k | 0.51% $ 7.7m | |
| Independent Director | 8.6yrs | US$106.65k | 0.094% $ 1.4m | |
| Independent Director | 6.2yrs | US$91.65k | 0.063% $ 944.7k | |
| Independent Director | 10.2yrs | US$114.15k | 0.10% $ 1.5m | |
| Independent Director | 7.9yrs | US$141.99k | no data | |
| Independent Director | 4.2yrs | US$91.65k | 0.047% $ 708.9k | |
| Independent Director | 3.2yrs | US$94.15k | 0.041% $ 616.5k |
8.3yrs
Average Tenure
58yo
Average Age
Experienced Board: ARDX's board of directors are considered experienced (8.3 years average tenure).